Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Non-response to consecutive antidepressant therapy caused by CYP2D6 ultrarapid metabolizer phenotype.

The international journal of neuropsychopharmacology - 1 Aug 2008

Breil Fleur, Verstuyft Celine, Orostegui Lupe, Buhl Catherine, Alvarez Jean-Claude, Chouinard Guy, Becquemont Laurent, Corruble Emmanuelle

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents
Share to Cytochrome P-450 CYP2D6
Share to Depression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Source

Identifiers

PMID: 18384706
DOI: 10.1017/S1461145708008742

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Non-response to consecutive antidepressant therapy caused by CYP2D6 ultrarapid metabolizer phenotype.PMID 18384706Read ↗

Ultrarapid metabolism of clomipramine in a therapy-resistant depressive patient, as confirmed by CYP2 D6 genotyping.Semantic proximity Read ↗

Aberrant CYP2D6 metabolizer phenotypes do not show increased frequency in patients undergoing ECT after antidepressant therapy.Semantic proximity Read ↗

Pharmacogenetics and the pharmacological management of depression.Semantic proximity Read ↗

[Clinical interest of CYP2D6 genotyping to treat depression in practice].Semantic proximity Read ↗

Association between CYP2D6 genotype and vortioxetine exposure and therapeutic failure - a retrospective, cohort studySemantic proximity Read ↗

Identification of CYP2D6 allelic mutations in a sub-set of Karachi populationSemantic proximity Read ↗

Identification of CYP2D6 allelic mutations in a sub-set of Karachi populationSemantic proximity Read ↗

Association between CYP2D6 genotype and treatment effectiveness and safety in 99 hospitalized patients with major depressive disorder - a retrospective cohort studySemantic proximity Read ↗

Does obtaining CYP2D6 and CYP2C19 pharmacogenetic testing predict antidepressant response or adverse drug reactions?Semantic proximity Read ↗

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants.Semantic proximity Read ↗

The impact of CYP allelic variation on antidepressant metabolism: a review.Semantic proximity Read ↗

Integrating Genetic Variants and Expression Profiles of Pharmacogenes to Investigate Resistance to Antidepressant Treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.